Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
Open-market buys, last 90 days
$20,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Verjee Rehan +$20K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-09-06 Swanson Ronald V. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +105,000 105,000
2022-09-06 Patel Piyush R. Chief Development Officer Grant or award · Stock Option (Right to Buy) +105,000 105,000
2022-09-06 Patel Piyush R. Chief Development Officer Grant or award · Stock Option (Right to Buy) +30,924 30,924
2022-09-06 Hudkins Robert L. Chief Technology Officer Grant or award · Stock Option (Right to Buy) +105,000 105,000
2022-09-06 Harris Todd Chief Executive Officer Grant or award · Stock Option (Right to Buy) +270,000 270,000
2022-09-06 Bensen Daniel Chief Operating Officer Grant or award · Stock Option (Right to Buy) +105,000 105,000
2022-09-06 Bensen Daniel Chief Operating Officer Grant or award · Stock Option (Right to Buy) +249,532 249,532
2022-06-13 Verjee Rehan Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-06-13 Subramony Siddarth Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-06-13 MORE ROBERT J Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-06-13 Kjellson Nina S Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-06-13 KAPLAN GILLA Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-06-13 CHEN ISAN Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-06-13 Simson Jake Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-06-13 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-05-16 Fawaz Ali D. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +2,301 2,301
2022-05-16 Fawaz Ali D. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +3,752 3,752
2022-05-16 Fawaz Ali D. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +361,586 361,586
2022-03-15 van den Boom Esther Chief Financial Officer Grant or award +1,800 $8.53 $15K 120,445
2022-03-15 Tada Hiroomi Chief Medical Officer Grant or award +2,703 $8.53 $23K 80,625

Page 17 of 21 · 417 trades